T1 bladder cancer: current considerations for diagnosis and management
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T1 bladder cancer: current considerations for diagnosis and management
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume 16, Issue 1, Pages 23-34
Publisher
Springer Nature
Online
2018-10-15
DOI
10.1038/s41585-018-0105-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review
- (2018) Ashish M. Kamat et al. EUROPEAN UROLOGY
- Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations
- (2018) Zachary Klaassen et al. EUROPEAN UROLOGY
- Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy
- (2018) Lu Wang et al. NATURE MEDICINE
- The evolution of bladder cancer genomics: What have we learned and how can we use it?
- (2018) François Audenet et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer
- (2017) Valeria Panebianco et al. EUROPEAN RADIOLOGY
- Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets
- (2017) Eugene J. Pietzak et al. EUROPEAN UROLOGY
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
- (2017) Lars Dyrskjøt et al. EUROPEAN UROLOGY
- Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset
- (2017) Woonyoung Choi et al. EUROPEAN UROLOGY
- Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification
- (2017) Gottfrid Sjödahl et al. JOURNAL OF PATHOLOGY
- Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Philippe E. Spiess et al. Journal of the National Comprehensive Cancer Network
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
- (2017) Arjun V Balar et al. LANCET ONCOLOGY
- The evolving genomic landscape of urothelial carcinoma
- (2017) Alexander P. Glaser et al. Nature Reviews Urology
- Characteristics and clinical significance of histological variants of bladder cancer
- (2017) Marco Moschini et al. Nature Reviews Urology
- ‘Real-life experience’: recurrence rate at 3 years with Hexvix® photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC—a prospective controlled study
- (2017) Kevin M. Gallagher et al. WORLD JOURNAL OF UROLOGY
- Genomic characterization of response to chemoradiation in urothelial bladder cancer
- (2016) Neil B. Desai et al. CANCER
- Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
- (2016) Jakob Hedegaard et al. CANCER CELL
- Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin
- (2016) Ashish M. Kamat et al. EUROPEAN UROLOGY
- The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging–Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging–Assisted TURBT in Primary Non–Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results
- (2016) Seiji Naito et al. EUROPEAN UROLOGY
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
- (2016) Samantha Cambier et al. EUROPEAN UROLOGY
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours
- (2016) Peter A. Humphrey et al. EUROPEAN UROLOGY
- High-Risk of Adverse Pathologic Features in Patients With Clinical T1 High-Grade Bladder Cancer Undergoing Radical Cystectomy
- (2016) Richard S. Matulewicz et al. Journal of the National Comprehensive Cancer Network
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
- (2016) Sam S. Chang et al. JOURNAL OF UROLOGY
- The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder
- (2016) Romain Mathieu et al. Nature Reviews Urology
- Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer
- (2016) Vladimir Novotny et al. UROLOGIA INTERNATIONALIS
- Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III
- (2016) Thorsten Bach et al. WORLD JOURNAL OF UROLOGY
- Genomic characterization of high-risk non-muscle invasive bladder cancer
- (2016) Joshua J. Meeks et al. Oncotarget
- The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin
- (2015) Paolo Gontero et al. BJU INTERNATIONAL
- A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma
- (2015) Oliver Patschan et al. EUROPEAN UROLOGY
- Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013
- (2015) Luis Martínez-Piñeiro et al. EUROPEAN UROLOGY
- Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients
- (2015) Paolo Gontero et al. EUROPEAN UROLOGY
- Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
- (2015) William Martin-Doyle et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcomes of cT1 Micropapillary Bladder Cancer
- (2015) Daniel L. Willis et al. JOURNAL OF UROLOGY
- Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
- (2015) Ashish M. Kamat et al. Nature Reviews Urology
- Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients
- (2014) A Orsola et al. BRITISH JOURNAL OF CANCER
- Quality of diagnostic staging in patients with bladder cancer: A process-outcomes link
- (2014) Karim Chamie et al. CANCER
- Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection
- (2014) Thomas Seisen et al. CURRENT OPINION IN UROLOGY
- Clinical Outcome of Patients with T1 Micropapillary Urothelial Carcinoma of the Bladder
- (2014) Massimiliano Spaliviero et al. JOURNAL OF UROLOGY
- Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer
- (2014) Mahul B Amin et al. MODERN PATHOLOGY
- Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: A systematic review and meta-analysis
- (2014) Hyung Suk Kim et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Concordance and Clinical Significance of Uncommon Variants of Bladder Urothelial Carcinoma in Transurethral Resection and Radical Cystectomy Specimens
- (2014) Tommaso Cai et al. UROLOGY
- Clinical Value of T2-Weighted Imaging Combined with Diffusion-Weighted Imaging in Preoperative T Staging of Urinary Bladder Cancer
- (2013) Lian-Ming Wu et al. ACADEMIC RADIOLOGY
- Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy
- (2013) Jacob T. Ark et al. BJU INTERNATIONAL
- Recurrence of high-risk bladder cancer: A population-based analysis
- (2013) Karim Chamie et al. CANCER
- Hexyl Aminolevulinate–Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non–Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature
- (2013) Michael Rink et al. EUROPEAN UROLOGY
- Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
- (2013) Maximilian Burger et al. EUROPEAN UROLOGY
- 5-Year Outcome of a Randomized Prospective Study Comparing bacillus Calmette-Guérin with Epirubicin and Interferon-α2b in Patients with T1 Bladder Cancer
- (2013) Tammer Hemdan et al. JOURNAL OF UROLOGY
- Prognostic Significance in Substaging of T1 Urinary Bladder Urothelial Carcinoma on Transurethral Resection
- (2012) Wei-Chin Chang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
- (2012) Jorg Oddens et al. EUROPEAN UROLOGY
- Prognostic Interest in Discriminating Muscularis Mucosa Invasion (T1a vs T1b) in Nonmuscle Invasive Bladder Carcinoma: French National Multicenter Study with Central Pathology Review
- (2012) Morgan Rouprêt et al. JOURNAL OF UROLOGY
- Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours
- (2012) Hans Olsson et al. Scandinavian Journal of Urology
- Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review
- (2011) Sven van den Bosch et al. EUROPEAN UROLOGY
- A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage
- (2011) Bas W.G. van Rhijn et al. EUROPEAN UROLOGY
- Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis
- (2011) Daniel Canter et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Impact of Routine Second Transurethral Resection on the Long-Term Outcome of Patients with Newly Diagnosed pT1 Urothelial Carcinoma with Respect to Recurrence, Progression Rate, and Disease-Specific Survival: A Prospective Randomised Clinical Trial
- (2010) Rauf Taner Divrik et al. EUROPEAN UROLOGY
- Restaging TUR reduces recurrence and progression risk
- (2010) Guido Dalbagni Nature Reviews Urology
- Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort
- (2009) Hans-Martin Fritsche et al. EUROPEAN UROLOGY
- Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience
- (2009) Paramananthan Mariappan et al. EUROPEAN UROLOGY
- Quality control in transurethral resection of bladder tumours
- (2008) Harry W. Herr et al. BJU INTERNATIONAL
- Lymphovascular Invasion of Urothelial Cancer in Matched Transurethral Bladder Tumor Resection and Radical Cystectomy Specimens
- (2008) Lakshmi P. Kunju et al. JOURNAL OF UROLOGY
- Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials
- (2007) Jesus Fernandez-Gomez et al. EUROPEAN UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started